Novogene Co., Ltd. (SHA:688315)
China · Delayed Price · Currency is CNY 13.26
+0.36 (2.79%)
Aug 4, 2026, 3:00 PM CST
Novogene Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,371 | 5,379 | 5,063 | 9,714 | 10,561 | 16,528 | |
Market Cap Growth | -18.60% | 6.24% | -47.88% | -8.02% | -36.10% | - |
Enterprise Value | 3,840 | 3,944 | 3,876 | 8,844 | 9,833 | 15,840 |
Last Close Price | 13.26 | 13.23 | 12.41 | 23.09 | 26.08 | 40.72 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 33.17 | 32.22 | 25.73 | 54.56 | 59.59 | 73.39 |
Forward PE | 25.75 | 24.33 | 22.14 | 36.47 | 42.39 | 51.46 |
PS Ratio | 2.37 | 2.43 | 2.40 | 4.85 | 5.49 | 8.86 |
PB Ratio | 1.99 | 2.01 | 2.02 | 3.93 | 5.35 | 9.19 |
P/TBV Ratio | 2.03 | 2.05 | 2.07 | 4.03 | 5.52 | 9.42 |
P/FCF Ratio | 40.70 | 47.72 | 24.95 | 44.66 | 121.78 | 91.08 |
P/OCF Ratio | 21.75 | 24.79 | 13.13 | 29.07 | 34.75 | 56.32 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.70 | 1.79 | 1.84 | 4.42 | 5.11 | 8.49 |
EV/EBITDA Ratio | 13.08 | 15.08 | 11.60 | 29.05 | 31.41 | 45.62 |
EV/EBIT Ratio | 24.86 | 28.37 | 19.82 | 49.98 | 48.91 | 68.77 |
EV/FCF Ratio | 29.10 | 34.99 | 19.10 | 40.66 | 113.38 | 87.28 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 |
Debt / EBITDA Ratio | 0.23 | 0.25 | 0.12 | 0.13 | 0.15 | 0.12 |
Debt / FCF Ratio | 0.52 | 0.63 | 0.21 | 0.19 | 0.57 | 0.25 |
Net Debt / Equity Ratio | -0.58 | -0.63 | -0.64 | -0.60 | -0.50 | -0.57 |
Net Debt / EBITDA Ratio | -5.71 | -6.48 | -4.78 | -4.89 | -3.17 | -2.93 |
Net Debt / FCF Ratio | -11.81 | -15.04 | -7.87 | -6.85 | -11.45 | -5.62 |
Asset Turnover | 0.61 | 0.58 | 0.58 | 0.60 | 0.65 | 0.76 |
Inventory Turnover | 5.06 | 5.55 | 6.92 | 6.07 | 5.04 | 4.96 |
Quick Ratio | 2.16 | 1.97 | 2.05 | 1.94 | 1.61 | 1.57 |
Current Ratio | 2.62 | 2.41 | 2.31 | 2.31 | 1.95 | 1.87 |
Return on Equity (ROE) | 6.36% | 6.60% | 8.18% | 8.24% | 9.62% | 15.68% |
Return on Assets (ROA) | 2.58% | 2.29% | 3.38% | 3.33% | 4.25% | 5.89% |
Return on Invested Capital (ROIC) | 12.61% | 13.00% | 18.68% | 15.51% | 19.88% | 30.87% |
Return on Capital Employed (ROCE) | 5.60% | 5.10% | 7.70% | 7.10% | 10.00% | 12.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.03% | 3.10% | 3.89% | 1.83% | 1.68% | 1.36% |
FCF Yield | 2.46% | 2.10% | 4.01% | 2.24% | 0.82% | 1.10% |
Dividend Yield | 0.35% | 0.34% | 0.40% | 0.21% | 0.18% | 0.15% |
Payout Ratio | 12.46% | 12.13% | 9.86% | 10.93% | 13.69% | 1.10% |
Buyback Yield / Dilution | 2.81% | 0.68% | -1.31% | -0.47% | -4.14% | -5.86% |
Total Shareholder Return | 3.17% | 1.02% | -0.91% | -0.26% | -3.96% | -5.71% |